458
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Incidence of Mortality and Associated Factors Among Colorectal Cancer Patients at Oncology Units of Northwest Ethiopia: A Retrospective Cohort Study

ORCID Icon, & ORCID Icon
Pages 1445-1455 | Published online: 13 Apr 2022

References

  • Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–249. doi:10.3322/caac.21660
  • Araghi M, Soerjomataram I, Jenkins M, et al. Global trends in colorectal cancer mortality: projections to the year 2035. Int J Cancer. 2019;144(12):2992–3000. doi:10.1002/ijc.32055
  • WHO. Colorectal cancer. International agency for research on cancer; 2020. Available from: https://gco.iarc.fr/today/data/factsheets/cancers. Accessed April 6, 2022.
  • Safiri S, Sepanlou SG, Ikuta KS, et al. The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2019;4(12):913–933. doi:10.1016/S2468-1253(19)30345-0
  • Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70(3):145–164. doi:10.3322/caac.21601
  • Haggar FA, Boushey RP. Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg. 2009;22(4):191. doi:10.1055/s-0029-1242458
  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34. doi:10.3322/caac.21551
  • Wallace K, DeToma A, Lewin DN, et al. Racial differences in stage IV colorectal cancer survival in younger and older patients. Clin Colorectal Cancer. 2017;16(3):178–186. doi:10.1016/j.clcc.2016.11.006
  • Zhang L, Cao F, Zhang G, et al. Trends in and predictions of colorectal cancer incidence and mortality in China from 1990 to 2025. Front Oncol. 2019;9:98. doi:10.3389/fonc.2019.00098
  • Favoriti P, Carbone G, Greco M, et al. Worldwide burden of colorectal cancer: a review. Updates Surg. 2016;68(1):7–11. doi:10.1007/s13304-016-0359-y
  • Keum N, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol. 2019;16(12):713–732.
  • Dekker E, Tanis PJ, Vleugels JLA, et al. Colorectal cancer. Lancet. 2019;394(10207):1467–1480. doi:10.1016/S0140-6736(19)32319-0
  • Xie Y-H, Chen Y-X, Fang J-Y, Huang M, Wu M, Zhao X. Comprehensive review of targeted therapy for colorectal cancer. Signal Transduct Target Ther. 2020;5(1):1–30. doi:10.1038/s41392-019-0089-y
  • Chalya PL, Mchembe MD, Mabula JB, et al. Clinicopathological patterns and challenges of management of colorectal cancer in a resource-limited setting: a Tanzanian experience. World J Surg Oncol. 2013;11(1):1–9. doi:10.1186/1477-7819-11-88
  • Hamza A, Argaw Z, Gela D. Awareness of colorectal cancer and associated factors among adult patients in Jimma, South-West Ethiopia. 2020.
  • Baglioni P. The IARC perspective on colorectal cancer screening. N Engl J Med. 2018;379(3):301.
  • Padmanabhan S, Waly MI, Taranikanti V, et al. Modifiable and non-modifiable risk factors for colon and rectal cancer. In: Bioactive Components, Diet and Medical Treatment in Cancer Prevention. Springer; 2018:121–130.
  • Jayasekara H, English DR, Haydon A, et al. Associations of alcohol intake, smoking, physical activity and obesity with survival following colorectal cancer diagnosis by stage, anatomic site and tumor molecular subtype. Int J Cancer. 2018;142(2):238–250. doi:10.1002/ijc.31049
  • Carethers JM, Doubeni CA. Causes of socioeconomic disparities in colorectal cancer and intervention framework and strategies. Gastroenterology. 2020;158(2):354–367. doi:10.1053/j.gastro.2019.10.029
  • Augustus GJ, Ellis NA. Colorectal cancer disparity in African Americans: risk factors and carcinogenic mechanisms. Am J Pathol. 2018;188(2):291–303. doi:10.1016/j.ajpath.2017.07.023
  • López PJT, Albero JS, Rodríguez-Montes JA. Primary and secondary prevention of colorectal cancer. Clinical medicine insights. Gastroenterology. 2014;7:CGast. S14039.
  • Murphy N, Ward HA, Jenab M, et al. Heterogeneity of colorectal cancer risk factors by anatomical subsite in 10 European countries: a multinational cohort study. Clin Gastroenterol Hepatol. 2019;17(7):1323–1331. e6. doi:10.1016/j.cgh.2018.07.030
  • Rossi M, Usman A, Keshavarzian A, et al. Colorectal cancer and alcohol consumption—populations to molecules. Cancers. 2018;10(2):38. doi:10.3390/cancers10020038
  • Mehrabani D, Almasi-Hashiani A, Moshfeghi K, Khedmati E Survival rate and its predictors in colorectal cancer patients, Southern Iran. Middle East J Sci Res. 2012;12(8):1072–1077.
  • Onyoh EF, Hsu W-F, Chang L-C, et al. The rise of colorectal cancer in Asia: epidemiology, screening, and management. Curr Gastroenterol Rep. 2019;21(8):1–10. doi:10.1007/s11894-019-0703-8
  • Memirie ST, Habtemariam MK, Asefa M, et al. Estimates of cancer incidence in Ethiopia in 2015 using population-based registry data. J Glob Oncol. . 2018;4:1–11.
  • Timotewos G, Solomon A, Mathewos A, et al. First data from a population based cancer registry in Ethiopia. Cancer Epidemiol. 2018;53:93–98. doi:10.1016/j.canep.2018.01.008
  • Atinafu BT, Bulti FA, Demelew TM. Survival status and predictors of mortality among colorectal cancer patients in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: a retrospective followup study. J Cancer Prev. 2020;25(1):38. doi:10.15430/JCP.2020.25.1.38
  • Memirie ST, Habtemariam MK, Asefa M, et al. Estimates of cancer incidence in Ethiopia in 2015 using population-based registry data. J Glob Oncol. 2018;4:1–11. doi:10.1200/JGO.17.00175
  • Etissa EK, Assefa M, Ayele BT, Chuu C-P. Prognosis of colorectal cancer in Tikur Anbessa Specialized Hospital, the only oncology center in Ethiopia. PLoS One. 2021;16(2):e0246424. doi:10.1371/journal.pone.0246424
  • Deressa BT, Cihoric N, Tefesse E, et al. Multidisciplinary cancer management of colorectal cancer in Tikur Anbessa Specialized Hospital, Ethiopia. J Glob Oncol. 2019;5:1–7. doi:10.1200/JGO.19.00014
  • Tefera B, Assefa M, Abebe B, Rauch D. Patterns of cancer in University of Gondar Hospital: North-West Ethiopia. J Oncol Med Pract. 2016;1:106.
  • Klein JP, Van Houwelingen HC, Ibrahim JG, Scheike TH. Handbook of Survival Analysis. CRC Press; 2016.
  • Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
  • American Cancer Society. Colorectal cancer; 2020. Available from: https://www.cancer.org/cancer/colon-rectal-cancer. Accessed April 6, 2022.
  • Glasheen WP, Cordier T, Gumpina R, Haugh G, Davis J, Renda A. Charlson comorbidity index: ICD-9 update and ICD-10 translation. Am Health Drug Benefits. 2019;12(4):188.
  • Schoen RE, Razzak A, Yu KJ, et al. Incidence and mortality of colorectal cancer in individuals with a family history of colorectal cancer. Gastroenterology. 2015;149(6):1438–1445. e1. doi:10.1053/j.gastro.2015.07.055
  • Liu S, Zheng R, Zhang M, et al. Incidence and mortality of colorectal cancer in China, 2011. Chin J Cancer Res. 2015;27(1):22. doi:10.3978/j.issn.1000-9604.2015.02.01
  • Motsuku L, Chen WC, Muchengeti MM, et al. Colorectal cancer incidence and mortality trends by sex and population group in South Africa: 2002–2014. BMC Cancer. 2021;21(1):1–11. doi:10.1186/s12885-021-07853-1
  • Saidi H, Abdihakin M, Njihia B, et al. Clinical outcomes of colorectal cancer in Kenya. Ann Afri Surg. 2011;7. doi:10.4314/aas.v7i1.67029
  • Fang J-Y, Dong H-L, Sang X-J, et al. Colorectal cancer mortality characteristics and predictions in China, 1991–2011. Asian Pacific J Cancer Prev. 2015;16(17):7991–7995. doi:10.7314/APJCP.2015.16.17.7991
  • White A, Ironmonger L, Steele RJC, et al. A review of sex-related differences in colorectal cancer incidence, screening uptake, routes to diagnosis, cancer stage and survival in the UK. BMC Cancer. 2018;18(1):1–11. doi:10.1186/s12885-018-4786-7
  • Kim S-E, Paik HY, Yoon H, et al. Sex-and gender-specific disparities in colorectal cancer risk. World J Gastroenterol. 2015;21(17):5167. doi:10.3748/wjg.v21.i17.5167
  • Semnani S, Noorafkan Z, Aryaie M, et al. Determinants of healthcare utilisation and predictors of outcome in colorectal cancer patients from Northern Iran. Eur J Cancer Care (Engl). 2016;25(2):318–323. doi:10.1111/ecc.12313
  • Lee JH, Lee S-W. The roles of carcinoembryonic antigen in liver metastasis and therapeutic approaches. Gastroenterol Res Pract. 2017;2017:1–11. doi:10.1155/2017/7521987
  • Shen F, Cui J, Hong X, et al. Preoperative serum carcinoembryonic antigen elevation in stage I colon cancer: improved risk of mortality in stage T1 than in stage T2. Int J Colorectal Dis. 2019;34(6):1095–1104. doi:10.1007/s00384-019-03298-y
  • Baqar AR, Wilkins S, Staples M, et al. The role of preoperative CEA in the management of colorectal cancer: a cohort study from two cancer centres. Int J Surg. 2019;64:10–15. doi:10.1016/j.ijsu.2019.02.014
  • Nan J, Li J, Li X, et al. Preoperative serum carcinoembryonic antigen as a marker for predicting the outcome of three cancers. Biomark Cancer. 2017;9:1179299X17690142. doi:10.1177/1179299X17690142
  • Saito G, Sadahiro S, Okada K, et al. Relation between carcinoembryonic antigen levels in colon cancer tissue and serum carcinoembryonic antigen levels at initial surgery and recurrence. Oncology. 2016;91(2):85–89. doi:10.1159/000447062